Adult-onset Generalized Morphea

Last updated: February 11, 2020
Sponsor: University Hospital, Strasbourg, France
Overall Status: Active - Recruiting

Phase

N/A

Condition

Scleroderma

Treatment

N/A

Clinical Study ID

NCT04264728
7551
  • Ages > 18
  • All Genders

Study Summary

This study aimed to describe the demographical and clinical characteristics of a retrospective cohort of adult-onset GM and to investigate whether these findings differ between patients with an isomorphic and a symmetric pattern of lesion distribution.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Age of onset ≥ 18 years

  • Patients with generalized morphea as defined by criteria established by Laxer andZulian (4 or more morpheaform plaques larger than 3 centimeters that show tendency toconfluence and involve at least 2 different anatomic sites)

  • Availability of good-quality clinical photographs

  • Patient who, after being informed, has not expressed his or her opposition to there-use of his or her data for the purposes of this research

Exclusion

Exclusion Criteria:

  • Patients with linear morphea who met criteria for generalized morphea

  • Patient's opposition to participate

Study Design

Total Participants: 100
Study Start date:
December 01, 2019
Estimated Completion Date:
April 30, 2020

Connect with a study center

  • Service de dermatologie - Hôpital Civil de Strasbourg

    Strasbourg, 67091
    France

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.